Search from website
Search from website
Figure 1. Coomassie-stained SDS-PAGE analysis of monoclonal antibody to SARS-CoV-2 Spike RBD, clone 27B12. 4-12% gradient gel is used for analysis. Lane 1. Monoclonal antibody to SARS-CoV-2 Spike RBD, clone 27B12 (-DTT). Lane 2. Size Marker. Lane 3. Monoclonal antibody to SARS-CoV-2 Spike RBD, clone 27B12 (+DTT). Lane 4. Size Marker
Figure 2. HPLC analytical SEC for final product.
Figure 2. HPLC analytical SEC for final product.
Figure 4. Octet RED96e analysis, antibody was loaded on sensor for capture of Spike S1 protein.
(for reference only; data shown are from a single production batch at release and may not be representative of other batches)
Catalogue #
R1-157-100
Name
Human IgG1-kappa antibody to SARS CoV-2 S1 RBD (clone 27B12)
Target
SARS-CoV-2 virus
Target Description
SARS-CoV-2 virus (PBMCs isolated from patients recovered from SARS-CoV-2 infection, antibodies discovered by using HybriFree Technology)
Alternative Names
Spike glycoprotein, S glycoprotein
Uniprot ID
P0DTC2
Clonality
Human monoclonal
Clone
27B12
Class
hIgG1
Reactivity
SARS-CoV-2 Spike S1 RBD, also recognized SARS CoV-2 Trimeric Spike in Octet analysis.
Application
ELISA
Protocol
Concentration
1 mg/ml
Buffer
PBS pH 7.4
Shipping
Shipped on dry ice.
Storage
Store in -65...-85 °C. Avoid multiple freeze-thaw cycles.
This product is for research use only
TECHNICAL ASSISTANCE
Please refer any technical questions to
technical.support@icosagen.com
© 2026 Icosagen
